USA Antihelminthics Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Antihelminthics market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Antihelminthics market. Detailed analysis of key players, along with key growth strategies adopted by Antihelminthics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Astellas Pharma

    • AstraZeneca

    • ALLERGAN

    • Mentis Pharma

    • Abbott

    • Novartis

    • Bayer

    • ZEISS International

    • Johnson & Johnson

    • Pfizer

    • Merck & Co

    • Sanofi

    • GlaxoSmithKline

    By Type:

    • Benzimidazoles

    • Abamectin

    • Salicylanilides

    • Praziquantel

    • Other

    By End-User:

    • Schistosomiasis

    • Fasciolasis

    • Filariasis

    • Angiostrongylosis

    • Ascariasis

    • Giardiasis

    • Other

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Antihelminthics Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Antihelminthics Market Size and Growth Rate of Benzimidazoles from 2016 to 2027

      • 1.3.2 USA Antihelminthics Market Size and Growth Rate of Abamectin from 2016 to 2027

      • 1.3.3 USA Antihelminthics Market Size and Growth Rate of Salicylanilides from 2016 to 2027

      • 1.3.4 USA Antihelminthics Market Size and Growth Rate of Praziquantel from 2016 to 2027

      • 1.3.5 USA Antihelminthics Market Size and Growth Rate of Other from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Antihelminthics Market Size and Growth Rate of Schistosomiasis from 2016 to 2027

      • 1.4.2 USA Antihelminthics Market Size and Growth Rate of Fasciolasis from 2016 to 2027

      • 1.4.3 USA Antihelminthics Market Size and Growth Rate of Filariasis from 2016 to 2027

      • 1.4.4 USA Antihelminthics Market Size and Growth Rate of Angiostrongylosis from 2016 to 2027

      • 1.4.5 USA Antihelminthics Market Size and Growth Rate of Ascariasis from 2016 to 2027

      • 1.4.6 USA Antihelminthics Market Size and Growth Rate of Giardiasis from 2016 to 2027

      • 1.4.7 USA Antihelminthics Market Size and Growth Rate of Other from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Antihelminthics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Antihelminthics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Antihelminthics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Antihelminthics Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Antihelminthics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Antihelminthics by Major Types

      • 3.4.1 Market Size and Growth Rate of Benzimidazoles

      • 3.4.2 Market Size and Growth Rate of Abamectin

      • 3.4.3 Market Size and Growth Rate of Salicylanilides

      • 3.4.4 Market Size and Growth Rate of Praziquantel

      • 3.4.5 Market Size and Growth Rate of Other

    4 Segmentation of Antihelminthics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Antihelminthics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Antihelminthics in Schistosomiasis

      • 4.4.2 Market Size and Growth Rate of Antihelminthics in Fasciolasis

      • 4.4.3 Market Size and Growth Rate of Antihelminthics in Filariasis

      • 4.4.4 Market Size and Growth Rate of Antihelminthics in Angiostrongylosis

      • 4.4.5 Market Size and Growth Rate of Antihelminthics in Ascariasis

      • 4.4.6 Market Size and Growth Rate of Antihelminthics in Giardiasis

      • 4.4.7 Market Size and Growth Rate of Antihelminthics in Other

    5 Market Analysis by Regions

    • 5.1 USA Antihelminthics Production Analysis by Regions

    • 5.2 USA Antihelminthics Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Antihelminthics Landscape Analysis

    • 6.1 West USA Antihelminthics Landscape Analysis by Major Types

    • 6.2 West USA Antihelminthics Landscape Analysis by Major End-Users

    7 South USA Antihelminthics Landscape Analysis

    • 7.1 South USA Antihelminthics Landscape Analysis by Major Types

    • 7.2 South USA Antihelminthics Landscape Analysis by Major End-Users

    8 Middle West USA Antihelminthics Landscape Analysis

    • 8.1 Middle West USA Antihelminthics Landscape Analysis by Major Types

    • 8.2 Middle West USA Antihelminthics Landscape Analysis by Major End-Users

    9 Northeast USA Antihelminthics Landscape Analysis

    • 9.1 Northeast USA Antihelminthics Landscape Analysis by Major Types

    • 9.2 Northeast USA Antihelminthics Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Astellas Pharma

        • 10.1.1 Astellas Pharma Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 AstraZeneca

        • 10.2.1 AstraZeneca Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 ALLERGAN

        • 10.3.1 ALLERGAN Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Mentis Pharma

        • 10.4.1 Mentis Pharma Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Abbott

        • 10.5.1 Abbott Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Novartis

        • 10.6.1 Novartis Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Bayer

        • 10.7.1 Bayer Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 ZEISS International

        • 10.8.1 ZEISS International Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Johnson & Johnson

        • 10.9.1 Johnson & Johnson Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Pfizer

        • 10.10.1 Pfizer Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Merck & Co

        • 10.11.1 Merck & Co Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 Sanofi

        • 10.12.1 Sanofi Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

      • 10.13 GlaxoSmithKline

        • 10.13.1 GlaxoSmithKline Company Profile and Recent Development

        • 10.13.2 Market Performance

        • 10.13.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Antihelminthics Market Size and Growth Rate of Benzimidazoles from 2016 to 2027

    • Figure USA Antihelminthics Market Size and Growth Rate of Abamectin from 2016 to 2027

    • Figure USA Antihelminthics Market Size and Growth Rate of Salicylanilides from 2016 to 2027

    • Figure USA Antihelminthics Market Size and Growth Rate of Praziquantel from 2016 to 2027

    • Figure USA Antihelminthics Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Antihelminthics Market Size and Growth Rate of Schistosomiasis from 2016 to 2027

    • Figure USA Antihelminthics Market Size and Growth Rate of Fasciolasis from 2016 to 2027

    • Figure USA Antihelminthics Market Size and Growth Rate of Filariasis from 2016 to 2027

    • Figure USA Antihelminthics Market Size and Growth Rate of Angiostrongylosis from 2016 to 2027

    • Figure USA Antihelminthics Market Size and Growth Rate of Ascariasis from 2016 to 2027

    • Figure USA Antihelminthics Market Size and Growth Rate of Giardiasis from 2016 to 2027

    • Figure USA Antihelminthics Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Antihelminthics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Antihelminthics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Antihelminthics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Antihelminthics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Antihelminthics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Antihelminthics

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Antihelminthics by Different Types from 2016 to 2027

    • Table Consumption Share of Antihelminthics by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Benzimidazoles

    • Figure Market Size and Growth Rate of Abamectin

    • Figure Market Size and Growth Rate of Salicylanilides

    • Figure Market Size and Growth Rate of Praziquantel

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Antihelminthics by Different End-Users from 2016 to 2027

    • Table Consumption Share of Antihelminthics by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Schistosomiasis

    • Figure Market Size and Growth Rate of Fasciolasis

    • Figure Market Size and Growth Rate of Filariasis

    • Figure Market Size and Growth Rate of Angiostrongylosis

    • Figure Market Size and Growth Rate of Ascariasis

    • Figure Market Size and Growth Rate of Giardiasis

    • Figure Market Size and Growth Rate of Other

    • Table USA Antihelminthics Production by Regions

    • Table USA Antihelminthics Production Share by Regions

    • Figure USA Antihelminthics Production Share by Regions in 2016

    • Figure USA Antihelminthics Production Share by Regions in 2021

    • Figure USA Antihelminthics Production Share by Regions in 2027

    • Table USA Antihelminthics Consumption by Regions

    • Table USA Antihelminthics Consumption Share by Regions

    • Figure USA Antihelminthics Consumption Share by Regions in 2016

    • Figure USA Antihelminthics Consumption Share by Regions in 2021

    • Figure USA Antihelminthics Consumption Share by Regions in 2027

    • Table West USA Antihelminthics Consumption by Types from 2016 to 2027

    • Table West USA Antihelminthics Consumption Share by Types from 2016 to 2027

    • Figure West USA Antihelminthics Consumption Share by Types in 2016

    • Figure West USA Antihelminthics Consumption Share by Types in 2021

    • Figure West USA Antihelminthics Consumption Share by Types in 2027

    • Table West USA Antihelminthics Consumption by End-Users from 2016 to 2027

    • Table West USA Antihelminthics Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Antihelminthics Consumption Share by End-Users in 2016

    • Figure West USA Antihelminthics Consumption Share by End-Users in 2021

    • Figure West USA Antihelminthics Consumption Share by End-Users in 2027

    • Table South USA Antihelminthics Consumption by Types from 2016 to 2027

    • Table South USA Antihelminthics Consumption Share by Types from 2016 to 2027

    • Figure South USA Antihelminthics Consumption Share by Types in 2016

    • Figure South USA Antihelminthics Consumption Share by Types in 2021

    • Figure South USA Antihelminthics Consumption Share by Types in 2027

    • Table South USA Antihelminthics Consumption by End-Users from 2016 to 2027

    • Table South USA Antihelminthics Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Antihelminthics Consumption Share by End-Users in 2016

    • Figure South USA Antihelminthics Consumption Share by End-Users in 2021

    • Figure South USA Antihelminthics Consumption Share by End-Users in 2027

    • Table Middle West USA Antihelminthics Consumption by Types from 2016 to 2027

    • Table Middle West USA Antihelminthics Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Antihelminthics Consumption Share by Types in 2016

    • Figure Middle West USA Antihelminthics Consumption Share by Types in 2021

    • Figure Middle West USA Antihelminthics Consumption Share by Types in 2027

    • Table Middle West USA Antihelminthics Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Antihelminthics Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Antihelminthics Consumption Share by End-Users in 2016

    • Figure Middle West USA Antihelminthics Consumption Share by End-Users in 2021

    • Figure Middle West USA Antihelminthics Consumption Share by End-Users in 2027

    • Table Northeast USA Antihelminthics Consumption by Types from 2016 to 2027

    • Table Northeast USA Antihelminthics Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Antihelminthics Consumption Share by Types in 2016

    • Figure Northeast USA Antihelminthics Consumption Share by Types in 2021

    • Figure Northeast USA Antihelminthics Consumption Share by Types in 2027

    • Table Northeast USA Antihelminthics Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Antihelminthics Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Antihelminthics Consumption Share by End-Users in 2016

    • Figure Northeast USA Antihelminthics Consumption Share by End-Users in 2021

    • Figure Northeast USA Antihelminthics Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Astellas Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma

    • Figure Sales and Growth Rate Analysis of Astellas Pharma

    • Figure Revenue and Market Share Analysis of Astellas Pharma

    • Table Product and Service Introduction of Astellas Pharma

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of ALLERGAN

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ALLERGAN

    • Figure Sales and Growth Rate Analysis of ALLERGAN

    • Figure Revenue and Market Share Analysis of ALLERGAN

    • Table Product and Service Introduction of ALLERGAN

    • Table Company Profile and Development Status of Mentis Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mentis Pharma

    • Figure Sales and Growth Rate Analysis of Mentis Pharma

    • Figure Revenue and Market Share Analysis of Mentis Pharma

    • Table Product and Service Introduction of Mentis Pharma

    • Table Company Profile and Development Status of Abbott

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott

    • Figure Sales and Growth Rate Analysis of Abbott

    • Figure Revenue and Market Share Analysis of Abbott

    • Table Product and Service Introduction of Abbott

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of ZEISS International

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ZEISS International

    • Figure Sales and Growth Rate Analysis of ZEISS International

    • Figure Revenue and Market Share Analysis of ZEISS International

    • Table Product and Service Introduction of ZEISS International

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Merck & Co

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co

    • Figure Sales and Growth Rate Analysis of Merck & Co

    • Figure Revenue and Market Share Analysis of Merck & Co

    • Table Product and Service Introduction of Merck & Co

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.